Investigating the interactions of the 18 kDa translocator protein and its ligand PK11195 in planar lipid bilayers

Simple item page
dc.contributor.authorHatty, CRen_AU
dc.contributor.authorLe Brun, APen_AU
dc.contributor.authorLake, Ven_AU
dc.contributor.authorClifton, LAen_AU
dc.contributor.authorLiu, GJen_AU
dc.contributor.authorJames, Men_AU
dc.contributor.authorBanati, RBen_AU
dc.date.accessioned2016-08-16T06:35:15Zen_AU
dc.date.available2016-08-16T06:35:15Zen_AU
dc.date.issued2014-03en_AU
dc.date.statistics2016-08-16en_AU
dc.description.abstractThe functional effects of a drug ligand may be due not only to an interaction with its membrane protein target, but also with the surrounding lipid membrane. We have investigated the interaction of a drug ligand, PK11195, with its primary protein target, the integral membrane 18 kDa translocator protein (TSPO), and model membranes using Langmuir monolayers, quartz crystal microbalance with dissipation monitoring (QCM-D) and neutron reflectometry (NR). We found that PK11195 is incorporated into lipid monolayers and lipid bilayers, causing a decrease in lipid area/molecule and an increase in lipid bilayer rigidity. NR revealed that PK11195 is incorporated into the lipid chain region at a volume fraction of ~ 10%. We reconstituted isolated mouse TSPO into a lipid bilayer and studied its interaction with PK11195 using QCM-D, which revealed a larger than expected frequency response and indicated a possible conformational change of the protein. NR measurements revealed a TSPO surface coverage of 23% when immobilised to a modified surface via its polyhistidine tag, and a thickness of 51 Å for the TSPO layer. These techniques allowed us to probe both the interaction of TSPO with PK11195, and PK11195 with model membranes. It is possible that previously reported TSPO-independent effects of PK11195 are due to incorporation into the lipid bilayer and alteration of its physical properties. There are also implications for the variable binding profiles observed for TSPO ligands, as drug–membrane interactions may contribute to the apparent affinity of TSPO ligands. © 2013, Elsevier B.V.en_AU
dc.identifier.citationHatty, C. R., Le Brun, A. P., Lake, V., Clifton, L. A., Liu, G. J., James, M., & Banati, R. B. (2014). Investigating the interactions of the 18 kDa translocator protein and its ligand PK11195 in planar lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1838(3), 1019-1030. doi:10.1016/j.bbamem.2013.12.013en_AU
dc.identifier.govdoc6969en_AU
dc.identifier.issn0005-2736en_AU
dc.identifier.issue3en_AU
dc.identifier.journaltitleBiochimica et Biophysica Acta (BBA) - Biomembranesen_AU
dc.identifier.pagination1019-1030en_AU
dc.identifier.urihttp://dx.doi.org/10.1016/j.bbamem.2013.12.013en_AU
dc.identifier.urihttp://apo.ansto.gov.au/dspace/handle/10238/7326en_AU
dc.identifier.volume1838en_AU
dc.language.isoenen_AU
dc.publisherElsevieren_AU
dc.subjectLigandsen_AU
dc.subjectMembrane proteinsen_AU
dc.subjectNeutron reflectorsen_AU
dc.subjectLipidsen_AU
dc.subjectDrugsen_AU
dc.subjectCrystalsen_AU
dc.titleInvestigating the interactions of the 18 kDa translocator protein and its ligand PK11195 in planar lipid bilayersen_AU
dc.typeJournal Articleen_AU
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles